Status:
UNKNOWN
Epidemiology of Post-influenza Bacterial Pneumonia Due to a Panton-Valentine Leukocidin Positive Staphylococcus Aureus
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Influenza
Staphylococcus Aureus Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
Secondary bacterial influenza pneumonia caused by Panton-Valentine Leukocidin Positive Staphylococcus aureus is a rare complication but with poor prognosis. This pathology seems to affect young patien...
Eligibility Criteria
Inclusion
- Patient treated for post-influenza bacterial pneumonia due to a Panton-Valentine Leukocidin positive Staphylococcus aureus in intensive care unit
Exclusion
- Minor patient
- Patient under protective measurement
- Absence of bacteriological and / or virological documentation
Key Trial Info
Start Date :
October 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2018
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03367624
Start Date
October 1 2017
End Date
March 1 2018
Last Update
December 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baux
Nancy, France, 54000